What is PatientWing?
PatientWing operates a clinical trial network designed to offer innovative pathways for individuals seeking optional treatments. The platform aims to reduce the burden of participation and empower individuals to contribute to medical advancements. By making clinical trials more approachable, PatientWing seeks to accelerate the development of new disease-fighting therapies and transform the medical industry through meaningful patient experiences.
How much funding has PatientWing raised?
PatientWing has raised a total of $150K across 1 funding round:
Angel/Seed
$150K
Angel/Seed (2017): $150K with participation from Safeguard Scientifics
Key Investors in PatientWing
Safeguard Scientifics
Safeguard Scientifics is an investment and operational holding company that partners with technology-focused businesses. Their involvement suggests a strategic interest in PatientWing's technology and market potential within the healthcare sector.
What's next for PatientWing?
The substantial capital infusion, particularly the recent strategic investment, positions PatientWing for significant scaling and expansion. This funding is likely to be directed towards enhancing its network infrastructure, broadening its reach to patient populations, and forging new partnerships within the healthcare and pharmaceutical sectors. The company's focus on patient-centric solutions in clinical trial enrollment suggests a trajectory aimed at becoming a dominant force in facilitating medical research and therapeutic development.
See full PatientWing company page
